EHAB ZEKRI: Open Payments
NPI 1295306280 · MILFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,836 in 70 payments from 26 companies in 2025. Trend: 2023 $827 · 2024 $1,659 · 2025 $1,836
Food & beverage: $1,836
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $277 |
| Novo Nordisk Inc | 10 | $257 |
| KYOWA KIRIN, INC. | 4 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $136 |
| Abbott Laboratories | 1 | $115 |
| Xeris Pharmaceuticals, Inc. | 5 | $109 |
| Mannkind Corporation | 3 | $85 |
| Medtronic, Inc. | 4 | $80 |
| Madrigal Pharmaceuticals | 3 | $73 |
| Lilly USA, LLC | 3 | $72 |
Products named: Ozempic, EVENITY, CRYSVITA, Kerendia, FREESTYLE LIBRE 3, AFREZZA, REZDIFFRA, MOUNJARO.
Industry payments across MA — which companies pay providers there.
